Background: Measles virus (MeV) is monotypic, but genetic variation in the hemagglutinin H and nucleoprotein N genes can be analyzed by molecular epidemiologic techniques and used to study virus transmission patterns. The World Health Organization currently recognizes 8 clades (A-H) within which are 24 genotypes of MeV and one provisional genotype, d11. Genotype B3 is clearly the endemic genotype in most of African continent where it is widely distributed. We provide an update on the molecular characterization of wild-type MeVs that circulated in Cameroon between 2010 and 2011. Findings: Viral RNA was extracted directly from samples obtained from clinically diagnosed measles patients using QIAamp viral RNA Mini Kit. Reverse transcription and PCR amplification of 634 nucleotides of the N gene was performed using the SuperScript™ III One-Step. Sequence analysis of 450 of the 634 nucleotides using Clustal X 2.0 program for multiple alignments and Mega version 5 for phylogenic analysis indicated that all the viruses belonged to genotype B3 with two distinct clusters. Twenty three (77%) belonged to subgroup B3.1 and the other 7 (23%) belonged to B3.3 a recently described subtype. Circulation of cluster 3 was detected in the Far-North Region (5/7) particularly along the Chad-Cameroon border in 2010 and later in Yaounde (2/7 in Biyem-assi Health District) the capital city of Cameroon in 2011. Conclusion: This study highlights the endemic circulation in Cameroon of MeV B3 subtype 1, which probably has its source in the neighboring Nigeria, and the presence of the new subtype B3.3, suggesting a possible importation from Northern Africa where it was first described between 2008 and 2009. 
the endemic genotype in most of the African continent where it is widely distributed [2] .
In 1998, WHO implemented measles elimination strategies and recommended that virological surveillance be established in every country. Although this surveillance is well established in all WHO regions, in some areas it still not adequate [3] . The laboratory has two main functions in measles surveillance: monitoring and verifying virus transmission (confirmation of outbreaks and identification of virus strains); and monitoring susceptibility profile of the population [4] . In Cameroon, distinct patterns of measles incidence are found in two different areas. The three northern-most Regions (Far-North, North and Adamaoua) experience major epidemics every year. Seven southern Regions show evidence of experiencing major epidemics every third year [5] . Following coincident peaks in 2000-2001 in these two cycles resulting in an increase in measles incidence countrywide, measles laboratory surveillance was established in 2001. This surveillance consisted mainly of serological confirmation of suspected cases. Following the WHO Measles and Rubella Laboratory Network initiative to expand the capacity of the national laboratories for virus isolation and detection [6] , a reverse-transcription polymerase chain reaction (RT-PCR) was set up in the Centre Pasteur of Cameroon (CPC) National Reference Laboratory (NRL) for measles in early 2011. Although genetic characterization of wild-type viruses is an essential component of laboratory-base surveillance, there are very few African countries that use molecular tools for the surveillance of measles. This paper provides an update on the molecular ) primers [6] . From these amplicons, a (Figure 2a) which is clearly the endemic genotype in most of the African continent with the exception of the North African countries in the Eastern Mediterranean Region [3] . Since genotype B3 has been divided into 3 clusters [8] , the sequences from the 30 Cameroonian MeVs were compared to the sequences of other genotype B3 viruses that were available in the GenBank (Figure 2b) C2 DQ267530  C1 AF410987  F X84865  A DQ267520  G2 AF171232  G3 AF353622  G1 U01974  H1 AF045212  H2 AF045217  D1 D01005  D6 AF410992 /  D2 U64582  D7 AF243450  D8 FJ719484  D5 AF079555  D3 U01977  D4 U01977 Cameroonian viruses belong to two distinct clusters. Twenty three (77%) belonged to subgroup B3.1 and the other 7 (23%) belonged to B3.3. Although cluster 1 has previously been isolated in Central (Cameroon and Central African Republic), West (Ghana and Nigeria) and East (Kenya and Tanzania) African countries [9] [10] [11] , cluster 2, which was not found during our study appears to be more limited to Western Africa [12] . Nevertheless, cluster 3, which was recently and for the first time, described to have circulated during 2008 and 2009 in Northern Africa (Tunisia and Libya) [8] is also present in Cameroon. This is to our knowledge, the second report of this new subtype of genotype B3 in Africa, and its first description in Central Africa. Furthermore, the Cameroonian sequences were also compared to the other B3 sequences in MeaNS (data not shown). The results of this blast search show that 77% (corresponding to the above sub-group B3.1) of the sequences were probably imported from the neighbouring Nigeria as they display more than 98% identity with the strains that circulated in Nigeria between 2010 and 2011. For the remaining 23% (B3.3), 5 of them (one from Goulfey, Kousseri and Guere and two from Biyem-Assi Health Districts) showed a 100% identity between themselves and are 99.5% identical to a strain isolated in Madrid (Spain) in 2008 from a patient with history of recent travel to Equatorial Guinea. One strain from Guere Health District exhibits a 100% identity with the 6 strains isolated in Tunisia and Libya in 2008-2009 and described as cluster 3 [8] .
Circulation of cluster 3 was detected in the Far-North Region (5/7) particularly along the Chad-Cameroon border (Goulfey, Kousseri and Guere Health Districts) in 2010 and later in Yaounde (2/7 in Biyem-assi Health District) the capital city of Cameroon in 2011 (Figure 1 ) suggesting a probably importation of this subtype from Libya (in the Northern Africa) through Chad. It has been established after a five-year study that there are two distinct patterns of measles incidence in two different areas in Cameroon [5] . The three northern-most Regions experience major epidemics every year. Seven southern Regions show evidence of experiencing major epidemics every third year. The same patterns have been observed during the last decade and the reasons of these differences are not very clear since Cameroon is among the 31 countries with measles-containing vaccines coverage of 50-79% for infants (Vaccination coverage from WHO/UNICEF estimates 1980-2005, August 2006). Investigations should therefore be sustained to monitor the circulation of the MeV genotype B3 cluster 3 in the upcoming years in Cameroon (and in Central Africa) in order to assess its implication in multiple outbreaks faced every year especially in 2012 which extended to almost the entire country (8/10 Regions affected).
In conclusion, this study describes molecular characteristics of clade B measles viruses circulating in Cameroon with reports of recent isolates from 2010 to 2011. It also highlights the endemic circulation of MeV B3 subtype 1, which probably has its source in the neighbouring Nigeria, and the presence of the new subtype (B3.3), suggesting a possible importation from Northern Africa where it was first described between 2008 and 2009.
